Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-02-27
2010-11-02
Desai, Rita J (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S314000
Reexamination Certificate
active
07825254
ABSTRACT:
The invention pertains to heteroaromatic compounds that serve as effective phosphodiesterase (PDE) inhibitors. In particular, the invention relates to said compounds which are selective inhibitors of PDE10. The invention also relates to intermediates for preparation of said compounds; pharmaceutical compositions comprising said compounds; and the use of said compounds in a method for treating certain central nervous system (CNS) or other disorders.
REFERENCES:
patent: 5500427 (1996-03-01), Kubo et al.
patent: 5693652 (1997-12-01), Takase et al.
patent: 7250518 (2007-07-01), Magee et al.
patent: 2006/0111368 (2006-05-01), Osakada et al.
patent: WO 93/16071 (1993-08-01), None
F Zaragoza Dorwald Side Reactions in Organic Synthesis 2005, Wiley-VCH.
Victor Segarra, Phosphodiesterase inhibitory properties of losartin. Design and synthesis of new lead compounds, Bioorganic & Medicinal Chemistry Letters (1998), vol. 8, No. 5, pp. 505-510.
Helal Christopher J.
Hoover Dennis J.
Humphrey John M.
Verhoest Patrick R.
Butterfield Garth C.
Desai Rita J
Kispert Jennifer A.
Mabry John
Pfizer Inc.
LandOfFree
Heteroaromatic quinoline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroaromatic quinoline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroaromatic quinoline compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4157654